Checkpoint Therapeutics, Inc. Services Agreements
2 Contracts & Agreements
- Master Services Agreement between Samsung Biologics Co., Ltd. and Checkpoint Therapeutics, Inc., effective November 8, 2017 (Filed With SEC on November 6, 2020)
- BOARD ADVISORY SERVICES AGREEMENT (Filed With SEC on March 17, 2017)
